市場調查報告書
商品編碼
1403341
全球醫療保健分析市場預測 (-2030):按類型、組件、部署模型、應用程式、最終用戶和區域進行分析Healthcare Analytics Market Forecasts to 2030 - Global Analysis By Type, Component, Deployment Model, Application, End User and by Geography |
2023年,全球醫療保健分析市場規模為431億美元,預計2030年將達到1,465.1億美元,預測期內複合年成長率為19.1%。
有系統地應用資料分析工具和技術從龐大的醫療保健資料集提取模式、趨勢和見解被稱為醫療保健分析。醫療保健負責人可以利用高級分析、機器學習和統計建模的力量來做出改善患者治療結果、業務效率和整體醫療保健服務的決策。此外,醫療保健分析對於將原始資料轉化為可操作的資訊至關重要,從最佳化臨床工作流程和確定成本節約策略到疾病預防的預測模型。
2018 年 6 月發布的 MedPac 報告發現,雖然死亡率和 ED/就診率保持平穩,而再入院率下降,但每年可節省 20 億美元,並且基於價值的支付表明這種轉變正在取得進展。
不斷成長的醫療資料
隨著穿戴式科技、電子健康記錄(EHR) 和其他數位健康工具的普及,醫療保健資料正以前所未有的速度成長。此外,醫療保健分析解決了從大量且多樣化的資料中組織和獲取有價值的見解的問題,以支持基於證據的決策並改善患者照護。
資料品質和互通性問題
分析中的醫療資料的安全性和隱私性不斷受到日益複雜的網路威脅的挑戰。核准的存取或資料外洩事件會使病患隱私面臨風險,並降低對分析產品的信任。此外,解決此限制需要持續投資強大的網路安全措施、加密協議,並嚴格遵守資料保護標準,以降低資料安全漏洞的風險。
即時分析以促進更快的決策
透過整合醫療保健提供者的即時分析,可以實現快速、資料驅動的決策。這對於緊急應變和重症加護場景以及資源最佳化特別有用。此外,透過即時洞察,醫護人員可以更快地回應病患病情的變化,並做出更好的整體臨床決策。
指導不足和技能差距
缺乏具有醫療保健和分析經驗的專業人員會造成人才缺口,從而危及成功實施分析舉措的能力。此外,醫療保健組織應投資於人才發展、學術夥伴關係和培訓計劃,以縮小技能差距,並確保醫療保健工作者擁有充分利用分析解決方案所需的技能。
醫療保健分析市場受到了 COVID-19 爆發的重大影響。隨著人們對公共衛生的日益關注、對即時資料追蹤和應對病毒的需求以及遠端醫療服務的興起,強大的分析解決方案變得越來越重要。政府、醫療機構和研究機構利用該分析來更好地分配資源、模擬病毒的傳播並加快疫苗的分發。此外,COVID-19 的爆發加速了數位醫療技術的同化,從而增加了對分析工具的需求,以從海量的醫療記錄中提取有意義的見解。
雲端基礎市場預計將在預測期內成為最大的細分市場
市場佔有率最大的細分市場是雲端基礎的部署模型。雲端基礎的解決方案受到各行各業組織的高度青睞,因為它們提供了無與倫比的彈性、擴充性和可訪問性。透過利用雲端,企業可以從共用基礎設施中受益,從而無需大量硬體支出和內部維護。此外,該模型透過支援對資料和應用程式的無縫遠端訪問,促進了快速變化的數位環境中的彈性和協作。
預計製藥業在預測期內複合年成長率最高
預計製藥業的複合年成長率最高。製藥業正在迅速擴張,其特點是不斷創新、研發工作以及尋找新的治療方法。這種快速成長是由許多因素推動的,包括對生物製藥的日益重視、精準醫學的進步以及對新藥的需求。此外,隨著該產業應對大流行(COVID-19)等全球健康挑戰,加速研發工作也推動了成長。
預計北美將佔據全球醫療保健分析市場的最大佔有率。該地區的優勢有許多因素,包括高度發展的醫療保健系統、尖端的技術力以及對研發的重視。尤其美國,是一個主要參與者,擁有大量的生物技術和製藥公司、領先的醫療保健提供者和多元化的健康保險市場。此外,該地區還受益於醫療保健創新領域的穩定投資,並不斷擴大市場佔有率。
在全球醫療保健分析市場中,亞太地區的複合年成長率最高。許多關鍵因素推動了這種動態成長,包括中國和印度等國家的人口成長、醫療保健意識的提高以及醫療基礎設施投資的增加。此外,該地區的製藥和生技產業正在不斷擴張,醫療保健技術取得了重大進步,各國政府正在採取積極措施來改善醫療保健的可及性。
According to Stratistics MRC, the Global Healthcare Analytics Market is accounted for $43.10 billion in 2023 and is expected to reach $146.51 billion by 2030 growing at a CAGR of 19.1% during the forecast period. The methodical application of data analysis tools and techniques to extract patterns, trends, and insights from enormous healthcare data sets is known as healthcare analytics. Healthcare practitioners can improve patient outcomes, operational efficiency, and overall healthcare delivery by leveraging the power of advanced analytics, machine learning, and statistical modeling to inform their decisions. Moreover, healthcare analytics is critical to turning raw data into actionable intelligence, from optimizing clinical workflows and identifying cost-saving strategies to predictive modeling for disease prevention.
According to the MedPac report published in June 2018, as the readmission rate declined, mortality rate and ED/observation rates were stable, but two billion dollars in annual savings was observed, showing that the shift to value-based payments is creating headway.
Data on healthcare has increased at a rate never seen before, thanks to the widespread use of wearable technology, electronic health records (EHRs), and other digital health tools. Additionally, in order to support evidence-based decision-making and improve patient care, healthcare analytics tackles the problem of organizing and deriving valuable insights from this enormous and varied data landscape.
The security and privacy of healthcare data in analytics are continuously challenged by the growing sophistication of cyber threats. Incidents of unapproved access and data breaches can jeopardize patient privacy and reduce confidence in analytics products. Furthermore, to mitigate the risk of data security breaches, addressing this constraint necessitates ongoing investment in strong cybersecurity measures, encryption protocols, and strict adherence to data protection standards.
The ability to make quick, data-driven decisions is made possible for healthcare providers by the integration of real-time analytics. This is especially helpful for emergency response, critical care scenarios, and resource optimization. Moreover, healthcare practitioners can respond more quickly to changes in patient conditions and make better clinical decisions overall when they have access to real-time insights.
The lack of professionals with both healthcare and analytics experience creates a talent gap that jeopardizes analytics initiatives' ability to be implemented successfully. Additionally, healthcare organizations need to make investments in workforce development, academic partnerships, and training programs in order to close skill gaps and guarantee that healthcare professionals have the skills needed to fully utilize analytics solutions.
The market for healthcare analytics has been significantly impacted by the COVID-19 pandemic. Robust analytics solutions have become increasingly important due to the growing emphasis on public health, the requirement for real-time data to track and respond to the virus, and the rise in telehealth services. Analytics has been used by governments, healthcare organizations, and researchers to better allocate resources, model viral spread, and expedite vaccine distribution. Furthermore, the COVID-19 pandemic has expedited the assimilation of digital health technologies, thereby elevating the need for analytics tools to extract meaningful insights from the flood of medical records.
The segment with the largest market share is the cloud-based deployment model. Organizations in a wide range of industries strongly prefer cloud-based solutions because they provide unmatched flexibility, scalability, and accessibility. By using the cloud, companies can benefit from a shared infrastructure, which eliminates the need for large hardware expenditures and internal maintenance. Moreover, this model fosters flexibility and collaboration in a digital landscape that is changing quickly by enabling seamless remote access to data and applications.
The pharmaceutical industry segment is projected to have the highest CAGR. The pharmaceutical sector is expanding rapidly, and it is distinguished by ongoing innovation, R&D efforts, and the search for novel treatments. This rapid growth can be attributed to a number of factors, such as the growing emphasis on biopharmaceuticals, advances in precision medicine, and the need for new drugs. Additionally, the growth has been further fueled by the industry's response to global health challenges, such as the COVID-19 pandemic, which has accelerated research and development efforts.
It is projected that North America will hold the largest market share for healthcare analytics worldwide. Numerous elements contribute to the region's dominance, such as its highly developed healthcare system, its cutting-edge technological capabilities, and its heavy emphasis on research and development. With its large number of biotechnology and pharmaceutical companies, state-of-the-art healthcare providers, and diverse health insurance market, the United States in particular is a key player. Furthermore, the area benefits from a steady stream of investments in healthcare innovation, which increases its market share.
In the global healthcare analytics market, the Asia-Pacific region has the highest CAGR. Numerous important factors, such as a growing population, rising healthcare awareness, and rising investments in healthcare infrastructure across nations like China and India, are driving this dynamic growth. Moreover, the pharmaceutical and biotechnology industries are expanding in the region, healthcare technology is advancing significantly, and the government is taking proactive steps to increase healthcare accessibility.
Some of the key players in Healthcare Analytics market include Evidation Health, Inc., Cerner Corporation, IBM Corporation, MedeAnalytics, Inc., GE Healthcare, McKesson Corporation, Komodo Health, Inc., Allscripts Healthcare Solution Inc, Optum, Inc., Athenahealth, Inc., Epic Systems Corporation
In June 2023, IBM announced that it has entered into a definitive agreement with Vista Equity Partners to purchase Apptio Inc., a leader in financial and operational IT management and optimization software, for $4.6 billion. The acquisition of Apptio will accelerate the advancement of IBM's IT automation capabilities and enable enterprise leaders to deliver enhanced business value across technology investments.
In May 2023, Evidation and Myovant Sciences Ltd., a wholly owned subsidiary of Sumitovant Biopharma Ltd. announced results from a survey exploring the lived experiences of individuals with endometriosis and/or uterine fibroids. The survey results highlight the negative impacts of these conditions on employee and student experiences and quality-of-life, underscoring the need for conversations and accommodations that advance equity for these populations.
In February 2023, Oracle Corp. has signed a contract with Accenture to improve the training Department of Veterans Affairs clinicians receive on using the VA's Cerner Millennium-based electronic health record platform. Speaking with FedScoop, Oracle Executive Vice President Ken Glueck said Oracle-owned Cerner had determined it needed additional support from consultancy firm Accenture after identifying this as an area where program improvement is needed.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.